Purchase Order HHSN269200900214P

This firm-fixed-price purchase order, awarded by the National Institutes of Health (NIH) Clinical Center, provides for the continuation of collaborative research on ethical issues related to disability, reproductive ethics, and neuroscience, along with faculty support. The awardee, Dr. Steven D. Pearson, is an expert in ethical issues in healthcare systems, particularly managed care, technology assessment, and resource allocation. The contract has a ceiling value of $77,254.92 and a period of...

This is a federal contract award to the National Opinion Research Center (NORC), a non-profit research organization, for the development of a legal analysis and ethics framework for Patient-Centered Outcomes Research (PCOR). The $1,329,268 firm fixed-price contract was awarded by the U.S. Department of Health and Human Services (HHS) on September 23, 2015 under the Professional Services Schedule (PSS) contract vehicle. The contract has a period of performance through September 29, 2017. NORC...

This is a $1,135,259.18 cost-plus-fixed-fee delivery order awarded by the National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Social & Scientific Systems, Inc., a for-profit subsidiary of DLH Holdings Corp. The order supports epidemiology services for the "DIABETES METABOLITES AND METABOLOMICS IN THE SISTER STUDY" under the "SUPPORT SERVICES FOR EPIDEMIOLOGY" program. No set-aside was used. Social & Scientific Systems has...

This is a $71,964 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to The Trustees of Columbia University in the City of New York for in vivo testing of a lead CoQ10 biosynthesis inhibitor in an SK-BR-3 xenograph mouse model. The contract includes four studies to assess the properties, toxicology, and efficacy of the inhibitor, with the first study on pharmacokinetic properties and...

Public Responsibility In Medicine & Research, Inc. was awarded a $64,513 firm fixed price purchase order by the National Institutes of Health National Human Genome Research Institute to deliver a Tribal Research Ethics Capacity-building Consortium workshop. The workshop will address models of tribal research governance and ethical oversight, as outlined in the original solicitation. No major subcontractors or set aside designations were indicated. The workshop will take place in Boston...

The National Institutes of Health (NIH) Clinical Center awarded a $62,530 firm-fixed-price purchase order to David Thurman Wasserman, a bioethics expert from University Park, Maryland, to provide research and training services to the Department of Bioethics. The procurement is not set aside for any specific business type. The award is intended to enhance the Department's educational and research capabilities by leveraging Wasserman's specialized expertise in ethics, genetics, disabilities, and...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center to David Wasserman of Wasserman David Thurman, a for-profit organization, for the "Continuation of Collaborative Research on Ethical Issues Related to Disability, Reproductive Ethics, and Neuroscience and Faculty Support." The contract has a potential value of $280,647.62 and a completion date of November 29, 2023. It is not a...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $114,365 firm fixed price purchase order to Labcorp Early Development Laboratories Inc. to complete the pharmacokinetics portion of the Phase 1 RR-HNK study. Labcorp Early Development Laboratories, a subsidiary of Laboratory Corporation of America Holdings, will perform the work over a two-year period from July 2023 through June 2025 at its facility in Madison,...

This is a $34,648,112.00 cost-plus-fixed-fee definitive contract awarded by the Defense Health Agency to Westat, Inc. for Phase 2 clinical trials. The contract has no set-aside designation. Westat has subcontracted work to several entities, including the Regents of the University of Michigan, Xenotech LLC, Clinipace Inc., and Biologics Consulting Group, Inc. The University of Michigan will provide clinical and technical expertise, while the other subcontractors will contribute professional...

This is a delivery order issued under the Cancer Study Cohort Recruitment indefinite delivery/indefinite quantity (IDIQ) contract by the National Cancer Institute, part of the National Institutes of Health at the U.S. Department of Health and Human Services. The task order, valued at $2,295,410.23, was awarded to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit hospital and healthcare organization, to perform planning and preparation work for a cancer study. The...